XML 24 R7.htm IDEA: XBRL DOCUMENT v3.6.0.2
Consolidated Statements of Cash Flows - USD ($)
$ in Thousands
12 Months Ended
Dec. 31, 2016
Dec. 26, 2015
Dec. 27, 2014
OPERATING ACTIVITIES      
Net income $ 137,350 $ 147,689 $ 138,809
Adjustments to reconcile net income to net cash provided by operating activities:      
Depreciation and amortization of operating property 35,796 29,102 27,575
Non-cash interest charges 238 218 218
Provisions for losses on trade and other accounts receivable 5,735 5,890 5,315
Gains on sales/disposals of operating property (3,477) (216) (2,143)
Deferred income taxes, net 6,328 6,792 5,434
Stock-based compensation 2,747 6,925 6,797
Changes in operating assets and liabilities:      
(Increase) decrease in trade and other accounts receivable (6,233) 20,713 (60,454)
Decrease (increase) in other assets 9,298 (1,177) (9,046)
(Decrease) increase in accounts payable (9,598) 3,632 62,281
Increase (decrease) in other liabilities 288 1,222 (2,468)
Increase (decrease) in insurance claims 11,770 (4,768) (70,449)
NET CASH PROVIDED BY OPERATING ACTIVITIES 190,242 216,022 101,869
INVESTING ACTIVITIES      
Sales and maturities of investments 41,795 38,684 34,701
Purchases of investments (43,529) (44,238) (36,473)
Purchases of operating property (22,645) (4,804) (10,539)
Proceeds from sales of operating property 10,212 1,685 7,465
NET CASH USED BY INVESTING ACTIVITIES (14,167) (8,673) (4,846)
FINANCING ACTIVITIES      
Increase in cash overdraft 642 980 6,849
Dividends paid (14,332) (57,882) (27,606)
Payment for debt issue costs (1,048)    
Proceeds from exercises of stock options 2,329 1,459 3,760
Taxes paid in lieu of shares issued related to stock-based compensation plans (3,043) (2,225) (4,041)
Excess tax benefits from stock-based awards 1,386 671 2,500
Purchases of common stock (50,516) (161,152) (56,393)
Principal payments on capital lease obligations (47,492) (36,520) (37,416)
NET CASH USED BY FINANCING ACTIVITIES (112,074) (254,669) (112,347)
Effect of exchange rate changes on cash and cash equivalents 376 (2,104) (1,034)
Increase (decrease) in cash and cash equivalents 64,377 (49,424) (16,358)
Cash and cash equivalents at beginning of period 114,520 163,944 180,302
Cash and cash equivalents at end of period $ 178,897 $ 114,520 $ 163,944